@article{Spencer_2018,
title={Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR},
volume={103},
ISSN={1592-8721},
url={http://dx.doi.org/10.3324/haematol.2018.194118},
DOI={10.3324/haematol.2018.194118},
number={12},
journal={Haematologica},
publisher={Ferrata Storti Foundation (Haematologica)},
author={Spencer,
Andrew and Lentzsch,
Suzanne and Weisel,
Katja and Avet-Loiseau,
Hervé and Mark,
Tomer M. and Spicka,
Ivan and Masszi,
Tamas and Lauri,
Birgitta and Levin,
Mark-David and Bosi,
Alberto and Hungria,
Vania and Cavo,
Michele and Lee,
Je-Jung and Nooka,
Ajay K. and Quach,
Hang and Lee,
Cindy and Barreto,
Wolney and Corradini,
Paolo and Min,
Chang-Ki and Scott,
Emma C. and Chanan-Khan,
Asher A. and Horvath,
Noemi and Capra,
Marcelo and Beksac,
Meral and Ovilla,
Roberto and Jo,
Jae-Cheol and Shin,
Ho-Jin and Sonneveld,
Pieter and Soong,
David and Casneuf,
Tineke and Chiu,
Christopher and Amin,
Himal and Qi,
Ming and Thiyagarajah,
Piruntha and Sasser,
A. Kate and Schecter,
Jordan M. and Mateos,
Maria-Victoria},
year={2018},
month=sep,
pages={2079–2087} }